Las Vegas, NV -- (SBWIRE) -- 01/16/2014 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Gol Linhas Aereas Inteligentes SA (ADR)(NYSE:GOL), MediciNova, Inc.(NASDAQ:MNOV), Athersys, Inc.(NASDAQ:ATHX), Antares Pharma Inc(NASDAQ:ATRS)
Gol Linhas Aereas Inteligentes SA (ADR)(NYSE:GOL) was a volume gainer of 1.49 million shares and the average volume of the stock remained 1.17 million shares. The stock opened the session at $4.60 and finished at the end of the day at $4.65 and the stock escalated 0.43%.The market capitalization of the stock remained 1.30 billion. Gol Linhas Aéreas Inteligentes S.A., through its subsidiaries, engages in the air transportation of passengers, cargo, and mailbags in Latin America. Gol Linhas Aéreas Inteligentes S.A. was founded in 2001 and is headquartered in São Paulo, Brazil.
For How Long GOL will fight for Profitability? Read This Trend Analysis report
In the preceding trading session, MediciNova, Inc.(NASDAQ:MNOV) exchanged 1.50 million shares and the average volume remained 308,066.00 shares. The stock closed the session at $2.69 with the drop of -5.28%. MediciNova, Inc., a development stage biopharmaceutical company, focuses on acquiring and developing small molecule therapeutics for the treatment of serious diseases for the United States market. MediciNova, Inc. was founded in 2000 and is headquartered in La Jolla, California.
Why Should Investors Buy MNOV After the Recent Fall? Just Go Here and Find Out
Athersys, Inc.(NASDAQ:ATHX) enhanced 2.06% and its closing price was $3.96. The volume of the stock was 1.45 million shares and the average volume remained 2.20 million shares. The market capitalization of the stock remained 302.14 million. The beta of the stock remained 0.63. Athersys, Inc, a biotechnology company, focuses on the research and development in the field of regenerative medicine. The company was founded in 1995 and is based in Cleveland, Ohio.
Why Should Investors Buy ATHX After The Recent Gain? Just Go Here and Find Out
Antares Pharma Inc(NASDAQ:ATRS) exchanged 1.44 million shares in the previous trading session, and its average trading remained 1.42 million shares. ATRS advanced 0.41% and it closed the trading at $4.95. The market capitalization of the stock remained 631.69 million. Antares Pharma, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies, and topical gel-based medicines worldwide.
For How Long ATRS’s Gloss will Attract Investors? Find out via this report
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)